Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-10-0585
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Hypoxia Increases Androgen Receptor Activity in Prostate Cancer Cells

Cancer Research
Cancer ResearchOncology
2006English

Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer

Cancer Research
Cancer ResearchOncology
2017English

Heme Oxygenase 1 Impairs Glucocorticoid Receptor Activity in Prostate Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Maintaining and Reprogramming Genomic Androgen Receptor Activity in Prostate Cancer

Nature Reviews Cancer
Cancer ResearchOncology
2014English

Altered Androgen Receptor Activity Drives CHD1-Null Prostate Cancer

Cancer Discovery
Oncology
2019English

New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway

Clinical Cancer Research
Cancer ResearchOncology
2011English

Targeting Androgen Receptor and JunD Interaction for Prevention of Prostate Cancer Progression

Prostate
OncologyUrology
2014English

Flightless I Homolog Represses Prostate Cancer Progression Through Targeting Androgen Receptor Signaling

Clinical Cancer Research
Cancer ResearchOncology
2015English

Mechanisms of Acquired Resistance to Androgen Receptor Targeting Drugs in Castration-Resistant Prostate Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy